Literature DB >> 9920898

Distinct and common pathways in the regulation of insulin-like growth factor-1 receptor gene expression by angiotensin II and basic fibroblast growth factor.

K J Scheidegger1, J Du, P Delafontaine.   

Abstract

Angiotensin II (Ang II) and basic fibroblast growth factor (bFGF) are important modulators of cell growth under physiological and pathophysiological conditions. We and others have previously shown that these growth factors increase insulin-like growth factor-1 receptor (IGF-1R) number and mRNA in vascular smooth muscle cells and that this effect is transcriptionally regulated. To study the mechanisms and the signaling pathways involved, IGF-1R promoter reporter constructs were transiently transfected in CHO-AT1 cells that overexpress angiotensin AT1 receptors. Our findings indicate that Ang II and bFGF significantly increased IGF-1R promoter activity up to 7- and 3-fold, respectively. The effect induced by Ang II was mediated via a tyrosine kinase-dependent mechanism, since tyrphostin A25 largely inhibited the Ang II-induced increase in promoter activity. In addition, co-transfection of dominant negative Ras, Raf, and MEK1 or pretreatment with the MEK inhibitor PD 98059 dose-dependently decreased both the Ang II- and bFGF-induced increase in IGF-1R transcription and protein expression, suggesting that the Ras-Raf-mitogen-activated protein kinase kinase pathway is required for both growth factors. Reactive oxygen species have been shown to act as second messengers in Ang II-induced signaling, and activation of the transcription factor NF-kappaB is redox-sensitive. While co-transfection of dominant negative IkappaBalpha mutant completely inhibited the Ang II-induced increase in transcription, it had no effect on the bFGF signaling. In contrast, co-transfection studies indicated that the transcription factors STAT1, STAT3, and c-Jun and the Janus kinase 2 kinase are required in the signaling pathway of bFGF, whereas only dominant c-Jun inhibited the Ang II-induced effect. In summary, these data demonstrate that Ang II and bFGF increase IGF-1R gene transcription via distinct as well as shared pathways and have important implications for understanding growth-stimulatory effects of these growth factors on vascular cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920898     DOI: 10.1074/jbc.274.6.3522

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation.

Authors:  M van Eickels; H Vetter; C Grohé
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.

Authors:  Jan H von der Thüsen; Keren S Borensztajn; Silvia Moimas; Sandra van Heiningen; Peter Teeling; Theo J C van Berkel; Erik A L Biessen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.

Authors:  Yewei Ma; Liping Zhang; Tao Peng; Jizhong Cheng; Shilpa Taneja; Jiqiang Zhang; Patrice Delafontaine; Jie Du
Journal:  Endocrinology       Date:  2005-12-01       Impact factor: 4.736

4.  Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies.

Authors:  Sabrina Rizzolio; Gabriella Cagnoni; Chiara Battistini; Stefano Bonelli; Claudio Isella; Jo A Van Ginderachter; René Bernards; Federica Di Nicolantonio; Silvia Giordano; Luca Tamagnone
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

5.  MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis.

Authors:  Song Gao; Michael Wassler; Lulu Zhang; Yangxin Li; Jun Wang; Yi Zhang; Harnath Shelat; Jason Williams; Yong-Jian Geng
Journal:  Atherosclerosis       Date:  2013-11-19       Impact factor: 5.162

Review 6.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

7.  Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.

Authors:  Yusuke Higashi; Kevin Holder; Patrice Delafontaine
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

8.  IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia.

Authors:  Annika Scheffold; Billy Michael Chelliah Jebaraj; Eugen Tausch; Johannes Bloehdorn; Paolo Ghia; Anella Yahiaoui; Anna Dolnik; Tamara Jacqueline Blätte; Lars Bullinger; Rashmi Priyadharshini Dheenadayalan; Li Li; Christof Schneider; Shih-Shih Chen; Nicholas Chiorazzi; Sascha Dietrich; Martina Seiffert; Stacey Tannheimer; Hartmut Döhner; Daniel Mertens; Stephan Stilgenbauer
Journal:  Blood       Date:  2019-04-22       Impact factor: 22.113

9.  Angiotensin II increases angiogenesis by NF-κB-mediated transcriptional activation of angiogenic factor AGGF1.

Authors:  Wenxia Si; Wen Xie; Wenbing Deng; Yi Xiao; Sadashiva S Karnik; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  FASEB J       Date:  2018-04-11       Impact factor: 5.191

10.  MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.

Authors:  Long Guo; Yu Bai; Tianyu Ni; Yuan Li; Rong Cao; Shuzhe Ji; Shuzhen Li
Journal:  Int J Oncol       Date:  2021-05-26       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.